News

Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies

Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies

Business Wire · Oct 6, 2025
Mytos Advances Automated iPSC Manufacturing through Strategic Partnerships

Mytos Advances Automated iPSC Manufacturing through Strategic Partnerships

BioInformant · Sep 29, 2025
Mytos Inks Cell Therapy Manufacturing Deals with Three European Biotechs

Mytos Inks Cell Therapy Manufacturing Deals with Three European Biotechs

IQ Capital · Sep 3, 2025
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience

Mytos Announces Manufacturing Collaboration with Aspen Neuroscience

FirstWord Pharma · Jan 8, 2025
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson's Disease

Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson's Disease

Business Wire · Jan 8, 2025
This Startup Just Raised $19 Million To Bring An Industrial Revolution To Biology

This Startup Just Raised $19 Million To Bring An Industrial Revolution To Biology

Forbes · Nov 30, 2023

Request Info. Tell us a little about your program and we'll get the right team back to you.

Proof of Value. Prove fit before you scale. Rapidly validate technical fit and ROI on the iDEM platform.

DiscoveryWe understand your manufacturing goals and challenges to solve.
ScopingWe design a tailored study to prove your process can be automated and demonstrate the ROI of manufacturing with Mytos.
Proof of ValueWe translate your process and run the study in our labs to generate proof points.